A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 499,192 shares of CSTL stock, worth $13.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
499,192
Previous 53,777 828.26%
Holding current value
$13.7 Million
Previous $1.17 Million 1116.75%
% of portfolio
0.04%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.4 - $31.47 $7.75 Million - $14 Million
445,415 Added 828.26%
499,192 $14.2 Million
Q2 2024

Aug 14, 2024

BUY
$18.84 - $24.94 $1.01 Million - $1.34 Million
53,777 New
53,777 $1.17 Million
Q3 2023

Nov 14, 2023

BUY
$13.28 - $20.3 $586,976 - $897,260
44,200 New
44,200 $746,000
Q1 2023

May 15, 2023

BUY
$19.47 - $28.49 $1.63 Million - $2.38 Million
83,466 Added 41.45%
284,847 $6.47 Million
Q4 2022

Feb 14, 2023

BUY
$18.08 - $30.0 $3.64 Million - $6.04 Million
201,381 New
201,381 $4.74 Million
Q2 2022

Aug 15, 2022

SELL
$16.0 - $45.99 $9.97 Million - $28.7 Million
-623,291 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$33.17 - $46.98 $4.66 Million - $6.6 Million
140,439 Added 29.09%
623,291 $28 Million
Q4 2021

Feb 14, 2022

BUY
$39.06 - $67.58 $14.8 Million - $25.7 Million
379,673 Added 367.98%
482,852 $20.7 Million
Q3 2021

Nov 15, 2021

BUY
$60.13 - $77.6 $6.2 Million - $8.01 Million
103,179 New
103,179 $6.86 Million
Q1 2021

May 17, 2021

SELL
$58.92 - $97.33 $4.78 Million - $7.9 Million
-81,145 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$43.6 - $73.05 $3.54 Million - $5.93 Million
81,145 New
81,145 $5.45 Million
Q3 2020

Nov 16, 2020

SELL
$38.47 - $52.03 $1.69 Million - $2.29 Million
-44,022 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$27.28 - $43.01 $449,083 - $708,030
16,462 Added 59.73%
44,022 $1.66 Million
Q1 2020

May 15, 2020

BUY
$23.08 - $35.53 $636,084 - $979,206
27,560 New
27,560 $822,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $724M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.